Skip to main content

Table 6 Adjusted period-specific hazard ratios (95% CI) for ITGA6 and Total CSC

From: Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance

Marker

Follow-up (years)

 

0 to 2

P-value

2 to 4

P-value

4 to 6

P-value

6 to 10

P-value

ITGA6

2.4 (1.2 to 5.0)

0.019

1.4 (0.72 to 2.7)

0.329

0.60 (0.17 to 2.1)

0.429

0.68 (0.15 to 3.1)

0.612

Total CSCs

1.6 (1.1 to 2.3)

0.007

1.4 (1.0 to 1.9)

0.050

1.0 (0.60 to 1.7)

0.994

0.86 (0.43 to 1.7)

0.666

  1. Adjusted for lymph node status, grade and tumour size. Analyses are of imputed data.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us